Ginkgo biloba Extract: Review of CNS Effects

References

• Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA: Recent patterns of medication use in the ambulatory adult population of the United States: The Slone Survey. JAMA 2002; 287(3):337–344
   PubMed Web of Science ®Google Scholar
• Anonymous: PDR for Herbal Medicines: Ginkgo biloba. 1st edn. Montvale, NJ: Medical Economics Co; 1998:871–873
   Google Scholar
• Tyler VE: The Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies, 3rd edn. New York: Pharma-ceutical Products Press; 1993:149–151
   Google Scholar
• Wincor MZ: Ginkgo biloba for dementia: A reasonable alter-native? JAPhA 1999; 39(3):415–416
   Google Scholar
• Chen C. Wei T. Gao Z, Zhao B, Hou J. Xu H, Xin W, Packer L: Different effect of the constituents of EGb761 on apoptosis in rat cerebellar granual cells induced by hydroxyl radicals. Biochem Mol Biol Int 1999; 47(3):397–405
   Google Scholar
• Bedir E. Tatli II, Khan RA, Zhao J, Takamatsu S. Walker LA, Goldman P, Khan IA: Biologically active secondary metabo-lites from Ginkgo biloba. J Agric Food Chem 2002; 50:3150–3155
   Google Scholar
• Sasaki K, Oota I, Wada K, Inomata K, Ohshika H, Haga M: Effects of bilobalide, a sesquiterpene in Ginkgo biloba leaves, on population spikes in rat hippocampal slices. Comp Biochem Physiol C 1999; 124:315–321
   Google Scholar
• Sasaki K, Hatta S, Haga M, Ohshika H: Effects of bilobalide on_ y-aminobutyric acid levels and glutantic acide decarboxylase in mouse brain. Eur J Pharmacol 1999; 367:165–173
   Google Scholar
• Chandrasekaran K, Mehrabian Z, Spinnewyn B, Drieu K, Fiskum G: Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Brain Res 2001; 922:282–292
   PubMed Web of Science ®Google Scholar
• Lenoir M, Pedruzzi E, Rais S, Drieu K, Perianin A: Sensiti-zation of human neutrophil defense activities through activa-tion of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761. Biochem Pharmacol 2002; 63:1241–1249
   Google Scholar
• Sloley BD, Urichuk U, Morley P, Durkin J, Shan JJ, Pang PKT, Coutts RT: Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacoi 2000; 52:451–459
   PubMed Web of Science ®Google Scholar
• McKenna DJ, Jones K. Hughes K: Efficacy, safety, and use of Ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med 2001; 7(5):70–90
   PubMed Web of Science ®Google Scholar
• Youdim KA, Joseph JA: A possible emerging role of phy-tochemicals in improving age-related neurological dysfunc-tion: A multiplicity of effects. Free Radical Biol Ivied 2001; 30(6):583–594
   PubMed Web of Science ®Google Scholar
• Alaoui-Youssefi A, Lamproglou I, Drieu K, Emerit I: Anti-clastogenic effects of Ginkgo biloba extract (EGb 761) and some of its constituents in irradiated rats. Ivlutat Res 1999; 445:99–104
   Google Scholar
• Nathan P: Can the cognitive enhancing effects of Ginkgo biloba be explained by its pharmacology? Med Hypotheses 2000; 55(6):491–493
   Google Scholar
• LeBars PL, Kieser M, Rd KZ: A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761 in dementia. Dement Geriatr Cogn Disord 2000; 11:230–237
   Google Scholar
• Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T. Riggins CW, Rister RS, eds.: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council; 1998:136–138
   Google Scholar
• Klepser TB, Klepser ME: Unsafe and potentially safe herbal therapies. Am J Health-Syst Pharm 1999; 56:125–138
   PubMed Web of Science ®Google Scholar
• Kleijnen J, Knipschild P: Ginkgo biloba. Lancet 1992; 340:1136–1139
   PubMed Web of Science ®Google Scholar
• Chavez ML, Chavez PI: Ginkgo (Part 2): Clinical efficacy, dosage, and adverse effects. Hosp Pharm 1998; 33(9):1076–1095
   Google Scholar
• Vacs LPJ, Chyka PA: Interactions of warfarin with garlic, gin-ger, ginkgo, or ginseng: Nature of the evidence. Ann Pharma-cotherapy 2000; 34:1478–1482
   Google Scholar
• Miller LG: Herbal medicines. Arch Intern Med 1998; 158(9):2200–2211
   Google Scholar
• Fugh-Berman A: Herb-drug interactions. Lancet 2000; 355:134–138
   PubMed Web of Science ®Google Scholar
• Maclennan KM, Darlington CL, Smith PF: The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiology 2002; 67:235–257
   PubMed Web of Science ®Google Scholar
• Gohil K: Genomic responses to herbal extracts: lessons from in vitro and in vivo studies with an extract of Ginkgo biloba. Biochem Pharmacol 2002; 64:913–917
   PubMed Web of Science ®Google Scholar
• Itil TM, Eralp E, Tsambis E, Itil KZ, Stein U: Central nervous system effects of Ginkgo biloba, a plant extract. Am J Therap 1996; 3:63–73
   PubMedGoogle Scholar
• Itil T, Martorano D: Natural substances in psychiatry (Ginkgo biloba in dementia). Psychopharmcol Bull 1995; 31(1):147–158
   Google Scholar
• Rigney U, Kimber S, Hindmarch I: The effects of acute doses of standardized Ginkgo biloba extract on memory and psy-chomotor performance in volunteers. Phytother Res 1999; 13:408–415
   PubMed Web of Science ®Google Scholar
• Allain H, Raoul P. Lieury A, LeCoz F, Gandon JM: Effect of two doses-of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin Ther 1993; 15:549–558
   PubMed Web of Science ®Google Scholar
• Sudhon Z, Hindmarch I: The pharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Int J Clin Pharmacol Res 1984; 4(2):89–93
   Google Scholar
• Hindmarch SZ: The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Int J Clin Pharm Res 1984; IV:89–93
   Google Scholar
• Kennedy DO, Scholey AB, Wesnes KA: The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology 2000; 151:416–423
   PubMed Web of Science ®Google Scholar
• Kennedy DO, Scholey AB, Wesnes KA: Differential, dose de-pendent changes in cognitive performance following acute ad-ministration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers. Nutr Neurosci 2001; 4:399–412
   PubMed Web of Science ®Google Scholar
• Wesnes KA, Ward T, McGinty A. Petrini O: The memory en-hancing effects of a Ginkgo bilobalPanax ginseng combination in healthy middle-aged volunteers. Psychopharmacology 2000; 152:353–361
   Google Scholar
• Mix JA, Crews WD: An examination of the efficacy of Ginkgo biloba extract EGB 761 on the nueropsychologic functioning of cognitively intact older adults. J Ahern Complementary Med 2000; 6(3):219–229
   PubMed Web of Science ®Google Scholar
• Stough C, Clarke J, Lloyd J, Nathan PJ: Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. Int J Neuropsychopharmacol 2001; 4:131–134
   PubMed Web of Science ®Google Scholar
• Moulton PL, Boyko LN, Fitzpatrick JL, Petros TV: The ef-fect of Ginkgo biloba on memory in healthy male volunteers. Physiol Behav 2001; 73:659–665
   PubMed Web of Science ®Google Scholar
• Solomon PR, Adams F, Silver A. Zimmer J, DeVeaux R: Ginkgo for memory enhancement: A randomized controlled trial. JAMA 2002; 288(7):835–840
   Google Scholar
• Ernst E, Pittler NIH: Ginkgo biloba for dementia: A systematic review of double-blind, placebo-controlled trials. Clin Drug Invest 1999; 17(4):30 I.-308
   Google Scholar
• Kanowski S. Herrmann WM, Stephan K, Wierich W, Hon- R: Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degen- erative dementia of alzheimer type or multi-infarct dementia. Pharmacopsychiatria 1996; 29:47–56
   Google Scholar
• Maurer K, Ihl R, Dierks T, Frolich L: Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res 1997; 31(6):645–655
   PubMed Web of Science ®Google Scholar
• Winther K, Randlov C, Rein E, Mehlsen J: Effects of Ginkgo biloba extract on cognitive function and blood pressure in el-derly subjects. Curr Therap Res 1998; 59(12):881–888
   Google Scholar
• LeBars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg A: A placebo-controlled, double-blind, random-ized trial of an extract of Ginkgo biloba for dementia. JAMA 1997; 278:1327–1332
   PubMed Web of Science ®Google Scholar
• Wettstein A: Cholinesterase inhibitors and Ginkgo extracts-are they comparable in the treatment of dementia? Phy-tomedicine 2000; 6(6):393–401
   Google Scholar
• Curtis-Prior C, Vere D, Fray P: Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function. J Pharm Pharmacol 1999; 51:535–541
   PubMed Web of Science ®Google Scholar
• LeBars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R: Influence of the severity of cognitive impair-ment on the effect of the Ginkgo biloba extract EGB 761® in Alzheimer's disease. Neuropsychobiology 2002; 45:19–26
   Google Scholar
• Van Dongen MCJM, van Rossum E, Kessels AGH, Sielhorst HJG, Knipschild PG: The efficacy of Ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial. J Am Geriatr Soc 2000; 48:1183–1194
   Google Scholar
• Agnoli A, Fiorani P. Pistolese GR: Preliminary results in the modifications of cerebral blood flow using xenon-133 dur-ing administration of Ginkgo biloba. Minerva Med 1973; 64(79 Suppl):4166–4173
   Google Scholar
• Barker PB, Yousem DM: Reproducibility of MR perfusion imaging with GdDTPA: Effect of Ginkgo biloba. Proc Intl Soc Mag Reson Med 2000; 8:1272
   Google Scholar
• Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Watkins GL, Ponto LLB, Hichwa RD: It. PET studies of mem-ory: Novel versus practiced free recall of word lists. Neuroim-age 1995; 2:296–305
   Google Scholar
• Schweizer J, Hautmann C: Comparison of two dosages of Ginkgo biloba extract EGb 761 in patients with periph-eral arterial occlusive disease Fontaine's Stage lib. Arzneim - Forsch/Drug Res 1999; 49(10:900–904
   Google Scholar
• Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C. Ritch R: Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Therap 1999; 15(3):233–240
   PubMedGoogle Scholar
• Krieglstein J. Beck T, Seibert A: Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci 1986; 39:2327–2334
   PubMed Web of Science ®Google Scholar
• Zhang WR, Hayashi T, Kitagawa H, Sasaki C, Sakai K, Warita H, Wang JM, Shiro Y, Uchida M, Abe K: Protective effect of Ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol Res 2000; 22:517–521
   PubMed Web of Science ®Google Scholar
• Rapin JR, Lafitte ML: Local cerebral glucose consumption: Effects of Ginkgo biloba extract. La Presse Medicale 1986; 15(30:1494–1497
   Google Scholar
• Loffler T, Lee SK, Noldner M, Chatterjee SS, Hoyer S. Schliebs R: Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brains. J Neural Transm 2001; 108:1457–1474
   Google Scholar
• Duverger D. Defeudis FV, Drieu K: Effects of repeated treat-ments with an extract of Ginkgo biloba (EGb 761) on cerebral glucose utilization in the rat: an autoradiographic study. Gen Pharac 1995; 26(6):1375–1383
   Google Scholar
• Janssens D, Nlichiels C, Guillaume G, Cuisinier B, Louagie Y. Remade J: Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: Protective effect of Ginkor Fort in a randomized double-blind, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999; 33:7–11
   Google Scholar
• Kurtsoy A, Canbay S, Oktem IS, Akdemir H, Koc RK, Menku A, Ricer B: Effect of EGb-761 on vasospasm in experimental subarachnoid hemorrhage. Res Exp Med 2000; 199:207–215
   Google Scholar
• Cheung F, Siow YL, Chen WZ, Karmin O: Inhibitory effect of Ginkgo biloba extract on the expression of inducible nitric oxide synthase in endothelial cells. Biochem Pharmacology 1999; 58:1665–1673
   PubMed Web of Science ®Google Scholar
• Varga E. Bodi A, Ferninandy P, Droy-Lefaiz MT, Blasig IE, Tosaki A: The protective effect of EGb 761 in isolated is-chemic/reperfused rat hearts: A link between cardiac function and nitric oxide production. J Cardiovascular Pharmacol 1999; 34:711–717
   PubMed Web of Science ®Google Scholar
• Pierre S, Jamme I, Droy-Lefaix MT, Nouvelot A, Maixent JM: Ginkgo biloba extract (EGb 761) protects Na, K-ATPase ac-tivity during cerebral ischemia in mice. NeuroReport 1999; 10:47–51
   PubMed Web of Science ®Google Scholar
• Wei T, Ni Y, Hou .1, Chen C, Zhao B, Xin W: Hydrogen peroxide-induced oxidative damage and apoptosis in cerebel-lar granule cells: Protection by ginkgo biloba extract. Pharma-col Res 2000; 41(4):427–433
   Google Scholar
• Wei Z, Peng Q, Lau RI-IS, Shah V: Ginkgo biloba inhibits hy-drogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells. Gen Pharmacol 1999; 33:369–375
   PubMedGoogle Scholar
• Welt K, Weiss J, Koch S, Fitzl G: Protective effects of Ginkgo biloba extract EGb 761 on the myocaridum of experiemtnally diabetic rats. Exp Toxic Pathol 1999; 51:213–222
   PubMed Web of Science ®Google Scholar
• Punkt K, Psinia I, Welt K, Barth W, Asmussen G: Effects on skeletal muscle fibres of diabetes and Ginkgo biloba extract treatment. Acta histochem 1999; 101:53–69
   Google Scholar
• Du G, Willet K, Mouithys'-Michalad A, Sluse-Goffart CM, Droy-Lefaix MT, Sluse FE: EGb 761 protects liver mitochon-dria against injury induced by in vitro anoxia/reoxygenation. Free Radical Biol Med 1999; 27(5/6):596–604
   Google Scholar
• Janssens D, Remade J, Drieu K, Michiels C: Protection of mi-tochondrial respiration activity by bilobalide. Biochem Phar-macol 1999; 58:109–119
   PubMed Web of Science ®Google Scholar
• Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA: Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res 2002; 70:357–360
   PubMed Web of Science ®Google Scholar
• Schindowski K, Leutner S, Kressmann S. Eckert A, Muller WE: Age-related increase of oxidative stress-induced apopto-sis in mice: Prevention by Ginkgo biloba extract (EGb761). Neural Transm 2001; 108:969–978
   Google Scholar
• Trovero F. Brochet D, TassinDrieu K: Ginkgo bilobaextract EGb761 reduces the development of amphetamine-induced behavioral sensitization: effects on hippocampal type II corticosteroid receptors. Brain Res 1999; 818:135–139
   Google Scholar
• Weichel O, Hilgert M, Chatterjee SS, Lehr M, Klein J: Bilob-alide, a constituent of Ginkgo biloba, inhibits NMDA-induced phosphalipase A2 activation and phospholipid breakdown in rat hippocampus. Nauyn-Schmiedeberg's Arch Pharmacol 1999; 360:609–615
   PubMed Web of Science ®Google Scholar
• Bastianetto S. Zheng WH, Quirion R: The Ginkgo biloba ex-tract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid con-stituents and protein kinase C. J Neurochem 2000; 74:2268–2277
   PubMed Web of Science ®Google Scholar
• Calapai G, Crupi A, Firenzuoli F, Marciano MC, Squadrito F, Inferrera G, Parisi A, Rizzo A, Crisafulli C, Fiore A, Caputi AP: Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci 2000; 67:2673–2683
   PubMed Web of Science ®Google Scholar
• Yao ZX, Drieu K, Szweda LI, Papadopoulos V: Free radical and lipid peroxidation do not mediate 0-amyloid-induced neu-ronal cell death. Brain Res 1999; 847:203–210
   PubMedGoogle Scholar
• Yao Zx, Drieu K, Papadopoulos V: The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from 13 amyloid-induced cell death by inhibiting the formation of fi amyloid-derived diffusible neurotoxic ligands. Brain Res 2001; 889:181–190
   PubMed Web of Science ®Google Scholar
• Bastianetto S, Ramassamy C, Dore S, Christen Y, Poirier J, Quirion R: The Ginkgo biloba extract (EGb 761) protects hip-pocampal neurons against cell death induced by fi amyloid. Eur J Neurosci 200012:1882-1890
   PubMed Web of Science ®Google Scholar
• Luo Y, Smith JV, Paramasivam V, Burdick A, Curry KJ, B uford JP, Khan I, Netzer WJ, Xu H, Butko P: Inhibition of amyloid-b aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. PNAS 2002; 99(19):12197–12202
   PubMed Web of Science ®Google Scholar
• Gajewski A, Hensch SA: Ginkgo biloba and memory for a maze. Psychol Rep 1999; 84:481–484
   Google Scholar
• Wirth S, Stemmelin J, Will B, Christen Y, Di Scala G: Facilita-tive effects of EGb 761 on olfactory recognition in young and aged rats. Pharmacol Biochem Behav 2000; 65(2):321–326
   Google Scholar
• Winter JC, Timineri D: The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba. Pharmacol Biochem Behav 1999; 62(3):543–547
   Google Scholar
• Wu WR, Zhu XZ: Involvement of monamine oxidase inhibi-tion in neuroprotective and neurorestorative effect of Ginkgo biloba extract against MPTP-induced nigrostriatal dopamin-ergic toxicity in C57 mice. Life Sci 1999; 65(2):157–164
   Google Scholar
• Pardon MC, Joubert C, Perez-Diaz F, Christen Y, Launay JM, Cohen-Salmon C: In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761). Mech Ageing Dev 2000; 113:157–168
   Google Scholar
• Porsolt RD, Roux S. Drieu K: Evaluation of a Ginkgo biloba extract (EGb 761) in functional tests for monamine oxidase inhibition. Arzneim-Forsch/Drug Res 2000; 50(I):232–235
   Google Scholar
• Fowler JS, Wang G-J, Volkow ND, Logan _I, Franceschi D, Franceschi M, MacGregor R. Shea C, Garza V, Liu N. Ding YS: Evidence that Ginkgo biloba extract does not inhibit MAO A and B in living human brain. Life Sci 2000; 66(9):141–146
   Google Scholar
• Larrabee GJ, McEntee Wl: Age associated memory impair-ment: Sorting out the controversies. Neurology 1995; 45:611–614
   PubMed Web of Science ®Google Scholar